Double Bolus Alteplase Therapy during Cardiopulmonary Resuscitation for Cardiac Arrest due to Massive Pulmonary Embolism Guided by Focused Bedside Echocardiography

Case Reports in Critical Care
Hafiz B Mahboob, Bruce W Denney

Abstract

Massive pulmonary embolism (PE) frequently leads to cardiac arrest (CA) which carries an extremely high mortality rate. Although available, randomized trials have not shown survival benefits from thrombolytic use. Thrombolytics however have been used successfully during resuscitation in clinical practice in multiple case reports and in retrospective studies. Recent resuscitation guidelines recommend using alteplase for PE related CA; however they do not offer a standardized treatment regimen. The most consistently applied approach is an intravenous bolus of 50 mg tissue plasminogen activator (t-PA) early during cardiopulmonary resuscitation (CPR). There is no consensus on the subsequent dosing. We present a case in which two 50 mg boluses of t-PA were administered 20 minutes apart during CPR due to persistent hemodynamic compromise guided by bedside echocardiogram. The patient had an excellent outcome with normalization of cardiac function and no neurologic sequela. This case demonstrates the benefit of utilizing bedside echocardiography to guide administration of a second bolus of alteplase when there is persistent hemodynamic compromise despite achieving return of spontaneous circulation after the initial bolus, and there is ...Continue Reading

References

Dec 1, 1992·The American Journal of Cardiology·J L DiehlH Sors
May 1, 1992·European Heart Journal·M GalleraniC Fersini
Oct 15, 1991·The American Journal of Cardiology·A N TenagliaE J Topol
Nov 1, 1991·The Annals of Thoracic Surgery·C SchmidH G Borst
Aug 15, 1996·The American Journal of Cardiology·M V McConnellR T Lee
Jul 1, 1997·European Heart Journal·M Kuisma, A Alaspää
Oct 23, 1997·Critical Care Medicine·P Varriale, J M Maldonado
Sep 16, 1999·Heart & Lung : the Journal of Critical Care·P Koutkia, T J Wachtel
Jan 27, 2000·Archives of Internal Medicine·P D Stein
May 29, 2000·Archives of Internal Medicine·I KürkciyanA N Laggner
May 31, 2003·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group
Jul 25, 2008·Echocardiography·Joseph A LodatoRoberto M Lang
Dec 2, 2008·The American Journal of Emergency Medicine·Brian T Fengler, William J Brady
Mar 23, 2011·Circulation·Michael R JaffUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology
Feb 14, 2012·The American Journal of Medicine·Paul D Stein, Fadi Matta
May 29, 2012·The American Journal of Emergency Medicine·Brian W LinCharles V Pollack
Apr 18, 2014·International Journal of Critical Illness and Injury Science·Raghav GuptaHope Cranston-D'Amato
Jul 31, 2014·The American Journal of Emergency Medicine·Qin YinChunsheng Li
Sep 1, 2014·European Heart Journal·Stavros V KonstantinidesUNKNOWN Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Jan 27, 2015·Pulmonary Circulation·Christian GergesIrene M Lang
Apr 22, 2015·European Heart Journal·S V KonstantinidesUNKNOWN Authors/Task Force Members
Dec 15, 2015·Case Reports in Emergency Medicine·Gerard O'ConnorPeadar Gilligan
Jul 17, 2016·The American Journal of Emergency Medicine·Mohsen SharifiUNKNOWN “PEAPETT” investigators
Dec 21, 2016·Circulation·Wulfran BougouinUNKNOWN Sudden Death Expertise Center

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.